Published in Arthritis Res Ther on September 22, 2010
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs. Arthritis Res Ther (2014) 1.35
Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study. Arthritis Care Res (Hoboken) (2012) 1.00
Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes (2014) 0.95
Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril (2011) 0.92
Work productivity in rheumatoid arthritis: relationship with clinical and radiological features. Arthritis (2012) 0.90
The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey. Rheumatology (Oxford) (2013) 0.88
Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation. United European Gastroenterol J (2014) 0.86
Quality appraisal of generic self-reported instruments measuring health-related productivity changes: a systematic review. BMC Public Health (2014) 0.86
Rheumatoid arthritis: should we shift the focus from "Treat to Target" to "Treat to Work?". Clin Rheumatol (2013) 0.86
Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis. J Multidiscip Healthc (2013) 0.80
Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis. Arthritis Care Res (Hoboken) (2016) 0.77
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set. RMD Open (2016) 0.77
An intervention to reduce sitting and increase light-intensity physical activity at work: Design and rationale of the 'Stand & Move at Work' group randomized trial. Contemp Clin Trials (2016) 0.75
Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment. BMC Dermatol (2014) 0.75
Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting. Clin Transl Allergy (2016) 0.75
Diagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in Europe. Pragmat Obs Res (2014) 0.75
Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity. Arthritis Res Ther (2016) 0.75
Efficacy of combined conservative therapies on clinical outcomes in patients with thumb base osteoarthritis: protocol for a randomised, controlled trial (COMBO). BMJ Open (2017) 0.75
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US. BMC Health Serv Res (2016) 0.75
Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR). BMC Dermatol (2017) 0.75
Large country differences in work outcomes in patients with RA - an analysis in the multinational study COMORA. Arthritis Res Ther (2017) 0.75
A power primer. Psychol Bull (1992) 63.66
The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics (1993) 7.19
The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am (2001) 3.58
Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) (2005) 2.51
Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum (1999) 2.41
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis (2002) 2.02
Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands. Soc Sci Med (2000) 2.01
Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care (1996) 1.95
PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoecon Outcomes Res (2005) 1.82
A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics (2004) 1.79
Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum (2001) 1.65
Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol (2010) 1.64
Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis (2004) 1.57
The validity and accuracy of the Work Productivity and Activity Impairment questionnaire--irritable bowel syndrome version (WPAI:IBS). Aliment Pharmacol Ther (2004) 1.55
Relationship of employee-reported work limitations to work productivity. Med Care (2003) 1.51
Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time. J Rheumatol (2007) 1.29
Validation of electronic data capture of the Irritable Bowel Syndrome--Quality of Life Measure, the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome and the EuroQol. Value Health (2006) 1.29
Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology (Oxford) (2010) 1.26
Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease. Clin Ther (2008) 1.16
Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.16
Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health (2008) 1.16
Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA). Arthritis Res Ther (2009) 1.10
The negative impact of psoriasis on the workplace. J Dermatolog Treat (2006) 1.03
Work and sick leave among patients with early inflammatory joint conditions. Arthritis Rheum (2008) 0.98
Predictors of sick leave and reduced productivity at work among persons with early inflammatory joint conditions. Scand J Work Environ Health (2008) 0.96
Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis. J Rheumatol (2008) 0.93
The Brazilian Portuguese version of the Work Productivity and Activity Impairment: General Health (WPAI-GH) Questionnaire. Sao Paulo Med J (2006) 0.92
Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. J Dermatolog Treat (2007) 0.88
Towards an ICF-based clinical measure of functioning in people with ankylosing spondylitis: a methodological exploration. Disabil Rehabil (2009) 0.88
The effects of rheumatoid arthritis on labor force participation, work performance, and healthcare costs in two workplace samples. J Occup Environ Med (2008) 0.88
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79
COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum (2002) 5.57
The financial cost of doctors emigrating from sub-Saharan Africa: human capital analysis. BMJ (2011) 4.54
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum (2005) 4.06
Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med (2013) 3.51
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med (2009) 3.03
Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) (2010) 2.67
Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum (2005) 2.20
Distinct psychological distress trajectories in rheumatoid arthritis: findings from an inception cohort. J Psychosom Res (2011) 2.20
Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ (2003) 2.18
Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (2005) 2.07
Fibromyalgia syndrome. J Rheumatol (2007) 2.04
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) (2009) 2.00
The effect of OSA on work disability and work-related injuries. Chest (2015) 1.96
Inequities in access to biologic and synthetic DMARDs across 46 European countries. Ann Rheum Dis (2013) 1.90
No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis (2010) 1.89
Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum (2002) 1.86
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum (2009) 1.75
Intensive care unit admission has minimal impact on long-term mortality. Crit Care Med (2002) 1.73
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum (2013) 1.67
The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies. Value Health (2009) 1.65
Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol (2010) 1.64
Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Phys (2006) 1.64
Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence. J Rheumatol (2002) 1.63
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction (2012) 1.62
Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis (2012) 1.62
Effect of sociodemographic factors on surgical consultations and hip or knee replacements among patients with osteoarthritis in British Columbia, Canada. J Rheumatol (2010) 1.57
Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11. J Rheumatol (2014) 1.56
The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open (2013) 1.55
Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum (2002) 1.55
Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum (2004) 1.54
Workplace, psychosocial factors, and depressive symptoms among working people with arthritis: a longitudinal study. J Rheumatol (2006) 1.54
Measuring and valuing productivity loss due to poor health: A critical review. Soc Sci Med (2010) 1.52
Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics (2005) 1.50
First-line DMARD choice in early rheumatoid arthritis--do prognostic factors play a role? Rheumatology (Oxford) (2009) 1.49
The Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project. J Rheumatol (2007) 1.44
Transgenerational occurrence of allergic disease and autoimmunity: general practice-based epidemiological research. Prim Care Respir J (2014) 1.44
Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. J Subst Abuse Treat (2010) 1.44
Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance. Rheumatology (Oxford) (2008) 1.43
Foot pain in rheumatoid arthritis prevalence, risk factors and management: an epidemiological study. Clin Rheumatol (2009) 1.42
Association between serum uric acid, aortic, carotid and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study. J Hypertens (2015) 1.42
Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia. Can J Neurol Sci (2009) 1.41
Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis. Rheumatology (Oxford) (2014) 1.40
The role of outcome measures in assessing change in the at-risk rheumatoid foot. J Tissue Viability (2004) 1.40
Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. CMAJ (2012) 1.37
Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum (2002) 1.35
Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health. J Rheumatol (2006) 1.35
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.33
Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis. Arthritis Rheum (2008) 1.28
A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care (2004) 1.27
Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol (2006) 1.27
HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J Acquir Immune Defic Syndr (2004) 1.27
Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis. Arthritis Rheum (2002) 1.26
Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol (2009) 1.26
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions. J Rheumatol (2003) 1.25
The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol (2008) 1.20
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr (2009) 1.19
Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum (2002) 1.18
The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care (2006) 1.17
Multiple treatment comparison meta-analyses: a step forward into complexity. Clin Epidemiol (2011) 1.16
Approval process and access to prescription drugs in Canada. Arthritis Rheum (2006) 1.15
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis (2007) 1.14
Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol (2009) 1.12
Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis. Patient Prefer Adherence (2013) 1.11
Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment. Arthritis Res Ther (2014) 1.11
Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res (Hoboken) (2013) 1.10
Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother (2003) 1.10
Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996-1997 through 2003-2004. Arthritis Rheum (2008) 1.10
Health related quality of life trajectories of patients in opioid substitution treatment. Drug Alcohol Depend (2011) 1.09
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res (2005) 1.08
Worker productivity outcome measures in arthritis. J Rheumatol (2007) 1.08
Now that we know what's BeSt, what is good value for the money? Arthritis Rheum (2009) 1.07
Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford) (2010) 1.06
Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information. Value Health (2013) 1.05
Arthritis-related work transitions: a prospective analysis of reported productivity losses, work changes, and leaving the labor force. Arthritis Rheum (2008) 1.05
Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the International Classification of Functioning, Disability and Health. Arthritis Rheum (2008) 1.04
Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice. Clin Exp Rheumatol (2011) 1.03
Reliability, validity, and responsiveness of five at-work productivity measures in patients with rheumatoid arthritis or osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.02
Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity--the early RA network (ERAN). Rheumatology (Oxford) (2010) 1.01
Epidemiology of spondyloarthritis. Rheum Dis Clin North Am (2012) 1.01
Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol (2002) 1.01
Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. J Rheumatol (2004) 1.00
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. J Rheumatol (2014) 1.00
Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study. Arthritis Care Res (Hoboken) (2012) 1.00
Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis. Arthritis Res Ther (2007) 1.00
Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol (2004) 1.00
The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. Health Policy (2006) 0.99
The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process. J Rheumatol (2007) 0.99
A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford) (2012) 0.98
Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage. J Rheumatol (2012) 0.98
TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev (2015) 0.98
Not 2 old 2 TXT: there is potential to use email and SMS text message healthcare reminders for rheumatology patients up to 65 years old. Health Informatics J (2011) 0.97
Predictors of early hospital readmission in HIV-infected patients with pneumonia. J Gen Intern Med (2003) 0.97